02096.HK
Simcere Pharmaceutical Group Limited
HKSE · Healthcare · Biotechnology · CN
HKD 10.14
−2.31%Margins
Gross margin
82.9%
EBITDA margin
23.8%
EBIT margin
20.9%
Net margin
18.0%
FCF margin
25.3%
16.5%
Return on equity
10.1%
Return on assets
15.3%
Return on invested capital
0.57x
Asset turnover
HKD 3.3B
Cash from operations
HKD 1.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026